menu
    • menu

    Company profile for Neurona Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Our initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery ...
    Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Our initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, we believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neurona TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    170 Harbor Way South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neuronatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurona-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neurona Therapeutics Names Dunayevich Chief Medical Officer
    Neurona Therapeutics Names Dunayevich Chief Medical Officer

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190481/0/en/Neurona-Therapeutics-Appoints-Dr-Eduardo-Dunayevich-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    EMA Grants PRIME Status to NRTX-1001 for Refractory Epilepsy
    EMA Grants PRIME Status to NRTX-1001 for Refractory Epilepsy

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181929/0/en/Neurona-Therapeutics-Announces-Priority-Medicines-PRIME-Designation-Granted-by-the-European-Medicines-Agency-EMA-to-NRTX-1001-in-the-Treatment-of-Drug-Resistant-Focal-Epilepsy.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Neurona Expands NRTX-1001 Cell Therapy Study In MTLE Without MTS
    Neurona Expands NRTX-1001 Cell Therapy Study In MTLE Without MTS

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162937/0/en/Neurona-Expands-Investigation-of-NRTX-1001-Cell-Therapy-into-Mesial-Temporal-Lobe-Epilepsy-MTLE-without-Mesial-Temporal-Sclerosis-MTS.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Neurona Reports Successful Preclinical Interneuron Cell Therapy
    Neurona Reports Successful Preclinical Interneuron Cell Therapy

    11 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/11/3114127/0/en/Neurona-Announces-Publication-in-Neuron-Reporting-Durable-Preclinical-Engraftment-of-Human-Interneuron-Cell-Therapy.html

    GLOBENEWSWIRE
    11 Jul 2025
    Share Share
    Neurona doses first patient in NRTX-1001 trial for MTLE
    Neurona doses first patient in NRTX-1001 trial for MTLE

    18 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/18/3101388/0/en/Neurona-Doses-First-Patient-in-Phase-1-2-Trial-of-NRTX-1001-Cell-Therapy-in-Adults-with-Drug-Resistant-Bilateral-Mesial-Temporal-Lobe-Epilepsy-MTLE.html

    GLOBENEWSWIRE
    18 Jun 2025
    Share Share
    Neurona Therapeutics Presents Positive Data from NRTX-1001 Trial
    Neurona Therapeutics Presents Positive Data from NRTX-1001 Trial

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057811/0/en/Neurona-Therapeutics-Presents-Positive-Clinical-Data-Update-from-NRTX-1001-Cell-Therapy-Trial-in-Drug-resistant-Epilepsy-at-American-Academy-of-Neurology-Annual-Meeting.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search